Cholesterol-lowering drugs may have a new use?reducing cancer, especially cancer of the kidney and prostate, according to the results of a Dutch study. The study, which looked at drug-dispensing records and hospital discharge records from 8 Dutch cities, found that statin use was connected with a 20% reduction in cancer risk.The researchers compared the use of statin drugs among 3219 patients with cancer and 16, 976 without cancer. All the participants were receiving at least 1 medication for cardiovascular disease.
Lead investigator Matthijs Graaf, PharmD, of the Academic Medical Center at the University of Amsterdam in the Netherlands, said, "People who used statins for less than 4 years did not have a significant risk reduction." The risk of cancer was 36% lower, however, in participants who took statins for at least 4 years, compared with that in people who did not take the drugs. Graaf stressed that more studies are needed before physicians advise patients to take statins solely as a means for decreasing the risk of cancer.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs